https://www.selleckchem.com/pr....oducts/Puromycin-2HC
Since December 2019, an outbreak of Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) initially emerged in Wuhan, China, and has spread worldwide now. Clinical features of patients with COVID-19 have been described. However, risk factors leading to in-hospital deterioration and poor prognosis in COVID-19 patients with severe disease have not been well identified. In this retrospective, single-center cohort study, 1190 adult inpatients (≥ 18years old) with laboratory-con
Like
Comment
Share
